Literature DB >> 15905556

Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse.

Evgueni A Ivakine1, Casey J Fox, Andrew D Paterson, Steven M Mortin-Toth, Angelo Canty, David S Walton, Katarina Aleksa, Shinya Ito, Jayne S Danska.   

Abstract

Many human autoimmune diseases are more frequent in females than males, and their clinical severity is affected by sex hormone levels. A strong female bias is also observed in the NOD mouse model of type I diabetes (T1D). In both NOD mice and humans, T1D displays complex polygenic inheritance and T cell-mediated autoimmune pathogenesis. The identities of many of the insulin-dependent diabetes (Idd) loci, their influence on specific stages of autoimmune pathogenesis, and sex-specific effects of Idd loci in the NOD model are not well understood. To address these questions, we analyzed cyclophosphamide-accelerated T1D (CY-T1D) that causes disease with high and similar frequencies in male and female NOD mice, but not in diabetes-resistant animals, including the nonobese diabetes-resistant (NOR) strain. In this study we show by genetic linkage analysis of (NOD x NOR) x NOD backcross mice that progression to severe islet inflammation after CY treatment was controlled by the Idd4 and Idd9 loci. Congenic strains on both the NOD and NOR backgrounds confirmed the roles of Idd4 and Idd9 in CY-T1D susceptibility and revealed the contribution of a third locus, Idd5. Importantly, we show that the three loci acted at distinct stages of islet inflammation and disease progression. Among these three loci, Idd4 alleles alone displayed striking sex-specific behavior in CY-accelerated disease. Additional studies will be required to address the question of whether a sex-specific effect of Idd4, observed in this study, is also present in the spontaneous model of the disease with striking female bias.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905556     DOI: 10.4049/jimmunol.174.11.7129

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Use of nonobese diabetic mice to understand human type 1 diabetes.

Authors:  Terri C Thayer; S Brian Wilson; Clayton E Mathews
Journal:  Endocrinol Metab Clin North Am       Date:  2010-07-08       Impact factor: 4.741

2.  γδ T cells are essential effectors of type 1 diabetes in the nonobese diabetic mouse model.

Authors:  Janet G M Markle; Steve Mortin-Toth; Andrea S L Wong; Liping Geng; Adrian Hayday; Jayne S Danska
Journal:  J Immunol       Date:  2013-04-26       Impact factor: 5.422

3.  Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells.

Authors:  I Hadjiyanni; K A Siminovitch; J S Danska; D J Drucker
Journal:  Diabetologia       Date:  2010-01-08       Impact factor: 10.122

4.  T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.

Authors:  Jonathan H Esensten; Michael R Lee; Laurie H Glimcher; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

5.  Status of autoimmune diabetes 20-year after generation of BDC2.5-TCR transgenic non-obese diabetic mouse.

Authors:  Lourdes Ramirez; Abdel Rahim A Hamad
Journal:  World J Diabetes       Date:  2013-08-15

6.  Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.

Authors:  Marcia McDuffie; Nelly A Maybee; Susanna R Keller; Brian K Stevens; James C Garmey; Margaret A Morris; Elizabeth Kropf; Claudia Rival; Kaiwen Ma; Jeffrey D Carter; Sarah A Tersey; Craig S Nunemaker; Jerry L Nadler
Journal:  Diabetes       Date:  2007-10-16       Impact factor: 9.461

7.  The unique genomic properties of sex-biased genes: insights from avian microarray data.

Authors:  Judith E Mank; Lina Hultin-Rosenberg; Matthew T Webster; Hans Ellegren
Journal:  BMC Genomics       Date:  2008-03-31       Impact factor: 3.969

8.  Genome-wide end-sequenced BAC resources for the NOD/MrkTac() and NOD/ShiLtJ() mouse genomes.

Authors:  Charles A Steward; Sean Humphray; Bob Plumb; Matthew C Jones; Michael A Quail; Stephen Rice; Tony Cox; Rob Davies; James Bonfield; Thomas M Keane; Michael Nefedov; Pieter J de Jong; Paul Lyons; Linda Wicker; John Todd; Yoshihide Hayashizaki; Omid Gulban; Jayne Danska; Jen Harrow; Tim Hubbard; Jane Rogers; David J Adams
Journal:  Genomics       Date:  2009-11-10       Impact factor: 5.736

9.  Genetic control of murine invariant natural killer T cells maps to multiple type 1 diabetes regions.

Authors:  S W Tsaih; S Khaja; A E Ciecko; E MacKinney; Y G Chen
Journal:  Genes Immun       Date:  2013-05-30       Impact factor: 2.676

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.